Evolving therapies in the treatment of hepatocellular carcinoma
Hans Christian Spangenberg, Robert Thimme, Hubert E BlumDepartment of Medicine II, University of Freiburg, D-79106 Freiburg, GermanyAbstract: Hepatocellular carcinoma (HCC) is one of the most common malignant tumors worldwide. The major etiologies and risk factors for HCC development are well define...
Enregistré dans:
Auteurs principaux: | Hans Christian Spangenberg, Robert Thimme, Hubert E Blum |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2008
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/f20bb1efe6c84d029414f049c8bd3235 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Systemic treatment for hepatocellular carcinoma
par: Manushi Aggarwal, et autres
Publié: (2018) -
Sorafenib for the treatment of unresectable hepatocellular carcinoma
par: Junji Furuse
Publié: (2008) -
Transcatheter Intra-Arterial Infusion Combined with Interventional Photothermal Therapy for the Treatment of Hepatocellular Carcinoma
par: Zhou J, et autres
Publié: (2020) -
Magnetite Nanoparticles and Spheres for Chemo- and Photothermal Therapy of Hepatocellular Carcinoma in vitro
par: Jędrzak A, et autres
Publié: (2020) -
Lactosylated liposomes for targeted delivery of doxorubicin to hepatocellular carcinoma
par: Zhou X, et autres
Publié: (2012)